Allergic conjunctivitis renders CD4+ T cells resistant to T regulatory cells and exacerbates corneal allograft rejection

N. J. Reyes, P. W. Chen, J. Y. Niederkorn

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Allergic diseases rob corneal allografts of immune privilege and increase immune rejection. Corneal allograft rejection in BALB/c allergic hosts was analyzed using a short ragweed (SWR) pollen model of allergic conjunctivitis. Allergic conjunctivitis did not induce exaggerated T-cell responses to donor C57BL/6 (B6) alloantigens or stimulate cytotoxic T lymphocyte (CTL) responses. Allergic conjunctivitis did affect T regulatory cells (Tregs) that support graft survival. Exogenous IL-4, but not IL-5 or IL-13, prevented Treg suppression of CD4+ effector T cells isolated from naïve mice. However, mice with allergic conjunctivitis developed Tregs that suppressed CD4+ effector T-cell proliferation. In addition, IL-4 did not inhibit Treg suppression of IL-4Rα-/- CD4+ T-cell responses, suggesting that IL-4 rendered effector T cells resistant to Tregs. SRW-sensitized IL-4Rα-/- mice displayed the same 50% graft survival as nonallergic WT mice, that was significantly less than the 100% rejection that occurred in allergic WT hosts, supporting the role of IL-4 in the abrogation of immune privilege. Moreover, exacerbation of corneal allograft rejection in allergic mice was reversed by administering anti-IL-4 antibody. Thus, allergy-induced exacerbation of corneal graft rejection is due to the production of IL-4, which renders effector T cells resistant to Treg suppression of alloimmune responses. The exacerbation of immune rejection of corneal transplants that occurs in mice with allergic conjunctivitis is due to allergen-induced IL-4, which renders immune effector T cells resistant to the inhibitory effects of T regulatory cells.

Original languageEnglish (US)
Pages (from-to)1181-1192
Number of pages12
JournalAmerican Journal of Transplantation
Volume13
Issue number5
DOIs
StatePublished - May 2013

Fingerprint

Allergic Conjunctivitis
Regulatory T-Lymphocytes
Interleukin-4
Allografts
T-Lymphocytes
Graft Rejection
Graft Survival
Corneal Diseases
Interleukin-13
Isoantigens
Interleukin-5
Cytotoxic T-Lymphocytes
Allergens
Hypersensitivity
Cell Proliferation
Antibodies

Keywords

  • Allergy
  • cornea
  • eye
  • T regulatory cells
  • tolerance

ASJC Scopus subject areas

  • Transplantation
  • Immunology and Allergy
  • Pharmacology (medical)

Cite this

Allergic conjunctivitis renders CD4+ T cells resistant to T regulatory cells and exacerbates corneal allograft rejection. / Reyes, N. J.; Chen, P. W.; Niederkorn, J. Y.

In: American Journal of Transplantation, Vol. 13, No. 5, 05.2013, p. 1181-1192.

Research output: Contribution to journalArticle

@article{fe617dc609e149fb81f8a4edcb97eb8b,
title = "Allergic conjunctivitis renders CD4+ T cells resistant to T regulatory cells and exacerbates corneal allograft rejection",
abstract = "Allergic diseases rob corneal allografts of immune privilege and increase immune rejection. Corneal allograft rejection in BALB/c allergic hosts was analyzed using a short ragweed (SWR) pollen model of allergic conjunctivitis. Allergic conjunctivitis did not induce exaggerated T-cell responses to donor C57BL/6 (B6) alloantigens or stimulate cytotoxic T lymphocyte (CTL) responses. Allergic conjunctivitis did affect T regulatory cells (Tregs) that support graft survival. Exogenous IL-4, but not IL-5 or IL-13, prevented Treg suppression of CD4+ effector T cells isolated from na{\"i}ve mice. However, mice with allergic conjunctivitis developed Tregs that suppressed CD4+ effector T-cell proliferation. In addition, IL-4 did not inhibit Treg suppression of IL-4Rα-/- CD4+ T-cell responses, suggesting that IL-4 rendered effector T cells resistant to Tregs. SRW-sensitized IL-4Rα-/- mice displayed the same 50{\%} graft survival as nonallergic WT mice, that was significantly less than the 100{\%} rejection that occurred in allergic WT hosts, supporting the role of IL-4 in the abrogation of immune privilege. Moreover, exacerbation of corneal allograft rejection in allergic mice was reversed by administering anti-IL-4 antibody. Thus, allergy-induced exacerbation of corneal graft rejection is due to the production of IL-4, which renders effector T cells resistant to Treg suppression of alloimmune responses. The exacerbation of immune rejection of corneal transplants that occurs in mice with allergic conjunctivitis is due to allergen-induced IL-4, which renders immune effector T cells resistant to the inhibitory effects of T regulatory cells.",
keywords = "Allergy, cornea, eye, T regulatory cells, tolerance",
author = "Reyes, {N. J.} and Chen, {P. W.} and Niederkorn, {J. Y.}",
year = "2013",
month = "5",
doi = "10.1111/ajt.12198",
language = "English (US)",
volume = "13",
pages = "1181--1192",
journal = "American Journal of Transplantation",
issn = "1600-6135",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Allergic conjunctivitis renders CD4+ T cells resistant to T regulatory cells and exacerbates corneal allograft rejection

AU - Reyes, N. J.

AU - Chen, P. W.

AU - Niederkorn, J. Y.

PY - 2013/5

Y1 - 2013/5

N2 - Allergic diseases rob corneal allografts of immune privilege and increase immune rejection. Corneal allograft rejection in BALB/c allergic hosts was analyzed using a short ragweed (SWR) pollen model of allergic conjunctivitis. Allergic conjunctivitis did not induce exaggerated T-cell responses to donor C57BL/6 (B6) alloantigens or stimulate cytotoxic T lymphocyte (CTL) responses. Allergic conjunctivitis did affect T regulatory cells (Tregs) that support graft survival. Exogenous IL-4, but not IL-5 or IL-13, prevented Treg suppression of CD4+ effector T cells isolated from naïve mice. However, mice with allergic conjunctivitis developed Tregs that suppressed CD4+ effector T-cell proliferation. In addition, IL-4 did not inhibit Treg suppression of IL-4Rα-/- CD4+ T-cell responses, suggesting that IL-4 rendered effector T cells resistant to Tregs. SRW-sensitized IL-4Rα-/- mice displayed the same 50% graft survival as nonallergic WT mice, that was significantly less than the 100% rejection that occurred in allergic WT hosts, supporting the role of IL-4 in the abrogation of immune privilege. Moreover, exacerbation of corneal allograft rejection in allergic mice was reversed by administering anti-IL-4 antibody. Thus, allergy-induced exacerbation of corneal graft rejection is due to the production of IL-4, which renders effector T cells resistant to Treg suppression of alloimmune responses. The exacerbation of immune rejection of corneal transplants that occurs in mice with allergic conjunctivitis is due to allergen-induced IL-4, which renders immune effector T cells resistant to the inhibitory effects of T regulatory cells.

AB - Allergic diseases rob corneal allografts of immune privilege and increase immune rejection. Corneal allograft rejection in BALB/c allergic hosts was analyzed using a short ragweed (SWR) pollen model of allergic conjunctivitis. Allergic conjunctivitis did not induce exaggerated T-cell responses to donor C57BL/6 (B6) alloantigens or stimulate cytotoxic T lymphocyte (CTL) responses. Allergic conjunctivitis did affect T regulatory cells (Tregs) that support graft survival. Exogenous IL-4, but not IL-5 or IL-13, prevented Treg suppression of CD4+ effector T cells isolated from naïve mice. However, mice with allergic conjunctivitis developed Tregs that suppressed CD4+ effector T-cell proliferation. In addition, IL-4 did not inhibit Treg suppression of IL-4Rα-/- CD4+ T-cell responses, suggesting that IL-4 rendered effector T cells resistant to Tregs. SRW-sensitized IL-4Rα-/- mice displayed the same 50% graft survival as nonallergic WT mice, that was significantly less than the 100% rejection that occurred in allergic WT hosts, supporting the role of IL-4 in the abrogation of immune privilege. Moreover, exacerbation of corneal allograft rejection in allergic mice was reversed by administering anti-IL-4 antibody. Thus, allergy-induced exacerbation of corneal graft rejection is due to the production of IL-4, which renders effector T cells resistant to Treg suppression of alloimmune responses. The exacerbation of immune rejection of corneal transplants that occurs in mice with allergic conjunctivitis is due to allergen-induced IL-4, which renders immune effector T cells resistant to the inhibitory effects of T regulatory cells.

KW - Allergy

KW - cornea

KW - eye

KW - T regulatory cells

KW - tolerance

UR - http://www.scopus.com/inward/record.url?scp=84876893835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876893835&partnerID=8YFLogxK

U2 - 10.1111/ajt.12198

DO - 10.1111/ajt.12198

M3 - Article

C2 - 23489547

AN - SCOPUS:84876893835

VL - 13

SP - 1181

EP - 1192

JO - American Journal of Transplantation

JF - American Journal of Transplantation

SN - 1600-6135

IS - 5

ER -